Lineage Cell Therapeutics In shares owned by ProShare Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by ProShare Advisors
from 13F filings
Historical chart of ProShare Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by ProShare Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by ProShare Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $35k | 24k | 1.48 |
| 2023-09-30 | $20k | 17k | 1.18 |
| 2023-06-30 | $24k | 17k | 1.41 |
| 2022-03-31 | $36k | 24k | 1.53 |
| 2021-12-31 | $67k | 27k | 2.45 |
| 2021-09-30 | $40k | 16k | 2.49 |
| 2021-06-30 | $90k | 32k | 2.86 |
| 2019-12-31 | $13k | 15k | 0.89 |
| 2019-09-30 | $12k | 12k | 0.97 |